widely used as tumor markers for the follow up of minimal residual disease in childhood B-precursor acute lymphoblastic leukemia (ALL) by polymerase chain reaction (PCR). The major drawback of this approach is the risk of false-negative results due to clonal evolution. We investigated the stability of V62D63 rearrangements in a group of 56 childhood Bprecursor ALL patients by PCR and Southern blot analysis. At the PCR level, V62D63-to-Ja rearranged subclones (one pathway for secondary TCRG recombination) were demonstrated in 85.2% of V62D63-positive patients tested, which showed that small subclones are present in the large majority of patients despite apparently monoclonal TCRS Southern blot patterns. Sequence analysis of V62D63Ja rearrangements showed a biased Ja gene usage, with HAP05 and JaF in 26 of 32 and 6 of 32 clones, respectively. Compari-URING B-AND T-CELL differentiation, DNA sequences encoding the Ig and T-cell receptor (TCR) variable domains are formed by somatic recombination of variable (V), diversity (D), and joining (J) gene segments.' Rearrangements are mediated by recombination signal sequences (RSS) that flank the different gene segments.' Apart from combinatorial diversity, additional diversity at the junctional regions is generated by exonucleolytic nibbling of nucleotides from coding segment^,^ addition of small inverted complementary P-nucleotides to intact gene segments: and addition of nontemplate-encoded N-nucleotides by the enzyme terminal deoxynucleotidyl transferase (TdT)."." As Ig and TCR junctional regions are highly diverse, they are widely applied as tumor-specific markers for the monitoring of minimal residual disease (MRD) in lymphoproliferative disorder^.^.^
The TCRS locus consists of six V, three D, three J, and one CS gene segments and is located nested within the TCRa locus on chromosome 14.'0"3 During TCRaP commitment of differentiating T cells, CS is deleted by recombination of an upstream VS2 RSS (SRec) to a pseudo Ja gene segment (QJu).'~ Although Ig/TCR rearrangements are usually lineage-specific, crosslineage TCRS rearrangements/deletions son of V62DS3 rearrangement status between diagnosis and first relapse showed differences in seven of eight patients studied. In contrast, from first relapse onward, no clonal changes were observed in six patients studied. To investigate the occurrence of crosslineage TCRG rearrangements in normal B and T cells, fluorescence-activated cell sortersorted peripheral blood CD19+/CD3-and CD19-/CD3+ cell populations from three healthy donors were analyzed. V62D63 rearrangements were detected at low frequencies in both B and T cells, which suggests that V62-to-DS3 joining also occurs during normal B-cell differentiation. A model for crosslineage TCRG rearrangements in B-precursor ALL is deduced that explains the observed clonal changes between diagnosis and relapse and is compatible with muftistep leukemogenesis of B-precursor ALL.
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are found in 80% to 90% of B-precursor acute lymphoblastic leukemias
The TCRS rearrangement pattern in B-precursor ALL is highly restricted, with V62DS3 and DS2D63 in 70% and 10% of rearrangements, respectively.'* The remaining 20% is heterogeneous and has not been well characterized.Ix TCRS deletion in B-precursor ALL is frequently caused by VS2DS3-to-Ja joining,17 and recombination of more upstream VS/a gene segments into the Ja locus also occur. 16 The above rearrangement pattern led to the proposal of the hierarchical recombination pathway, germline (G) to V62D63 to VS2DS3Ja, as an alternative for C6 deletion by SRec/WJa recombination during T-cell differentiation.I7.l9 The observed TCRS rearrangement pattern in Bprecursor ALL is distinctly different from TCRS rearrangements in T-cell ALL (T-ALL) where predominantly complete VSlDSJSl rearrangements are f o~n d . '~,~" For the Ig heavy chain (IgH), oligoclonality has been observed in approximately 40% of B-precursor ALL cases by Southern blot analysis at diagnosis.2' In contrast, TCRS oligoclonality on Southern blot analysis is rare in B-precursor However, as TCRS rearrangement patterns in Bprecursor ALL are highly restricted," Southern blot analysis may be misleading in this respect. Moreover, the finding of ongoing V62D63-to-J~~ rearrangements in the B-precursor cell line Reh" and a limited number of B-precursor ALL cases" suggests also the instability of TCRS rearrangements. Additionally, frequent changes in rearrangement status between diagnosis and relapse have been reported.2',2' To investigate the extent of TCRS oligoclonality in B-precursor ALL, we performed a detailed polymerase chain reaction (PCR)-based analysis of TCR V62DS3 rearrangement status and the occurrence of ongoing V62D63-to-Ja rearrangements in 55 childhood B-precursor ALL patients and one pre-B ALL blast crisis of a child with chronic myeloid leukemia (CML). For 10 patients, rearrangement patterns at diagnosis and subsequent relapse and/or between relapses were compared. To address the occurrence of TCRS rearrangements along the G-to-VS2DS3-to-VS2DbJa pathway during normal B-and T-cell differentiation, we estimated the number of V62D63 and V62D63Ja rearrangements in peripheral blood B and T cells. Our data on the TCRG rearrangement process in B-precursor ALL have implications for monitoring MRD by PCR and give insight into the biological behavior of the disease.
MATERIALS AND METHODS
Patient materials. Bone marrow samples from 55 childhood Bprecursor ALL patients (one null ALL CD19+, CD10-, cIgM-; 45 common ALL CD19+, CD10+, cIgM-; nine pre-B ALL CD19+, CD10+, cIgM+) and one juvenile CML patient who presented with a pre-B ALL blast crisis were obtained at diagnosis and/or relapse. Informed consent was obtained from all patients and/or their parents according to the rules of the Academic Medical Center (Amsterdam, The Netherlands). Cytogenetic analysis was performed using both the direct and 24-hour culture methods.
DNA isolation. The mononuclear cell fraction was isolated by density gradient centrifugation (Ficoll-isopaque, density = 1.077 g/ pL; Pharmacia, Uppsala, Sweden). Per DNA isolation, 2 X lo6 cells were proteinase K-digested for 12 hours at 50°C in 500 pL TE buffer (10 mmol/L Tris-HC1, pH 7.5/0.2 mmol/L EDTA) containing 100 pg/mL proteinase K (Merck, Darmstadt, Germany) and 0.5% sodium dodecyl sulfate (SDS). DNA was phenouchloroform-extracted, alcohol-precipitated, redissolved in 200 pL TE, and stored at -20°C.
For DNA isolation from bone marrow smears, cells were scraped from the slides. Erythrocytes were lysed for 5 minutes in 500 pL water. Cells were pelleted by centrifugation at 13,OOOg for 10 minutes. Pellet was resuspended in 500 pL 0.1% wt/vol NP40 for 10 minutes at room temperature. Nuclei were pelleted by centrifugation at 13,OOOg for 10 minutes. Proteinase K digestion, phenokhloroform extraction, and alcohol precipitation were performed as described above. This procedure yielded 50 to 500 ng DNA per smear.
Southern blot analysis. High-molecular-weight DNA was isolated according to standard procedure^.'^ Southern blot analysis was performed as de~cribed.2~ The H24 JH probe is a 2.5-kb EcoRIIBgl I1 restriction fragment. 26 The J61 probe is a 1.5-kb Sac USac I restriction fragment" and was provided by J.J.M. van Dongen (Erasmus University, Rotterdam, The Netherlands). PCR. All PCR primers were synthesized on a DNA synthesizer (Applied Biosystems model 392, Palo Alto, CA) and purified with oligonucleotide purification cartridges (Applied Biosystems, Foster City, CA). Primer sequences and locations are shown in Fig 1. For the amplification of TCR V62D63 rearrangements, a two-step seminested PCR approach was applied. First round PCR was performed with primer set 1/5. One microliter of first-round PCR product served as template for a second round of PCR with primer set 2/5. Amplification of V62D63Ja rearrangements and the germline V62 gene were similarly performed applying primer sets 1/6-U6 and 113-2/3, respectively. The two-round V62D63 and germline V62 PCR assays allow the detection of a single template molecule after gel electrophoresis and ethidium bromide staining (unpublished data).
Reactions were performed in 50-pL mixtures and contained 1 pg genomic DNA, 50 mmol/L KCl, 10 mmol/L Tris-HC1 pH 9.0.0.1 % (wt/vol) Triton X-100, 1.8 mmoVL MgC12, 200 pmol/L of each deoxynucleotide triphosphate (dNTP; Pharmacia), 2 U Taq Polymerase (Promega, Madison, WI), and 300 n m o m of each primer. The reaction protocol was performed in a thermal cycler (Perkin Elmer Cetus model 480, Nonvalk, CT) and consisted of 10 minutes at 95°C followed by 35 cycles of 1 minute at 95"C, 1 minute at 55°C 2 minutes at 72"C, and 7 minutes at 72°C. Second-round PCR consisted of 30 cycles with identical conditions. In the first round of TCRG amplification from bone marrow smears, a primer set that amplifies IgH CDR3 regions (FR3/JH21)*' was included as an internal control for amplification efficiency and DNA template quality.
Direct sequencing of V62D63 junctional regions. PCR product was size-separated on a 20 X 20-cm 8% acrylamide gel. Positive bands were excised from the gel. Product was eluted from the gel slices for 1 hour at 55°C in 50 pL water. One microliter of the elution volume was used as template for 30 cycles of reamplification with primer set 2/5. Two microliters of second-round PCR product was directly used as template in the sequencing reaction. Twenty sequencing cycles of 10 seconds at 95°C and 10 seconds at 65°C were performed with the BRL Cycle Sequencing Kit (BRL, Gaithersburg, MD), using one of the PCR primers endlabeled with 32P (Amersham, Amersham, UK). Products were always sequenced on both strands to eliminate sequencing artifacts.
For the fingerprinting analysis, V62D63 PCR products were similarly subjected to 20 sequencing cycles with the modification that dNTPs were omitted from the termination mix used. The sample was subsequently analyzed by acrylamide/urea sequencing gel electrophoresis.
Hybridization with V62D63 oligonucleotide probes. Hybridization in fluid phase was performed as described p r e v i o~s l y .~~ Oligonucleotides (1 8 to 20 mers) complementary to the TCR V62D63 junctional region were synthesized on a DNA synthesizer (Applied Biosystems model 392). Hybridization mixtures were prepared in 0.5-mL Eppendorf tubes and contained 5 pL PCR product, 4 pL 20X standard saline citrate (SSC) and 30 pL water. Unpurified oligonucleotide (80 ng) was endlabeled with 40 pCi "P gamma deoxyadenosine triphosphate (dATp, Amersham), and nonincorporated nucleotides were removed with a sephadex G-50 column. Approximately 1 ng oligonucleotide (1 pL) was added to the hybridization mixtures, which were subsequently overlaid with mineral oil. The hybridization reactions were performed in a thermal cycler (Perkin Elmer Cetus model 480). The protocol was identical for all oligonucleotides and consisted of 10 minutes at 95°C followed by 15 minutes at 60°C and cooling to 20°C. Ten microliters of the hybridization mixture was size-separated by electrophoresis through 10% acrylamide minigels (Hoefer Scientific Instruments, San Francisco, CA) to separate free oligonucleotides from the oligonucleotidePCR product complexes. Gels were dried, and films were exposed at -70°C with intensifying screens for 24 to 48 hours.
Subcloning of V62D63Ju products. Second-round PCR product (primers 216 or 217) was size-separated by electrophoresis through a 2% low melting agarose gel (BRL). Products of the appropriate size were excised from the gel and purified with the Qiaex (Diagen Diisseldorf, Germany) gel extraction kit according to the manufacturer's instructions. Subcloning was performed using the pGEM-T vector cloning system (Promega), according to the manufacturer's instructions. Ten positive colonies were screened by one lane se- CD19'~h' cell populations, respectively, were sorted with a FACSstar cell sorter (Becton Dickinson). Sorted cell populations used in the experiments were greater than 99.9% pure. Quantification was based on the limiting dilution principle and the ability of two-round heminested PCR to amplify a single template molecule to a quantity visible after gel electrophoresis and ethidium bromide staining. DNA was isolated as described above. The DNA equivalent of 1.5 X IO5 cells, fivefold serially diluted into water, served as template in the PCRs. Two independent serial dilutions were tested for each donor. All PCRs were two-step seminested and performed as described above. V62DS3, V62DS3Ja, and VS2-gemline were amplified with primer pairs 1/5-2/5, 116-216, and 113-2/3, respectively. Amplification of the 0-globin first exon with primer pairs PC03/GH21 and KM38/GH2I3" served as control for DNA input. Two independent serial dilutions were tested for each donor.
RESULTS

VS2D63 rearrangement status.
TCR V62DS3 rearrangements were amplified from bone marrow samples obtained at first diagnosis (49 patients) or relapse (7 patients) by a two-step seminested PCR approach with primer pairs 115 and 215 in the first and second round, respectively (Fig  1) . Of 56 patients, 30 (53.6%) were found to be VS2DS3-positive by acrylamide gel electrophoresis1ethidium bromide staining. Analysis of second-round PCR product by a fingerprinting technique, which involved size separation of "Plabeled V62D63 fragments on a sequencing gel, showed one, two, or three bands of equal intensity, compatible with monoclonaiity, in 26 of 30 patients (Table 1) . Four patients (patients 32, 53, 66, and 75) showed an oligoclonal pattern with bands of unequal intensity or multiple differently sized products (Fig 2) .
Southern blot analysis with the J61 probe" was in agreement with the PCR data, as PCR positivity always concurred with the presence an 1 l-kb V62D63 restriction fragment" in the Bgl I1 digest. In the four patients that were oligoclonal for VS2DS3 rearrangements by PCR, a weak 9.2-kb DS2D63 restriction fragment" (confirmed by PCR with primer pair 415) and unidentified restriction fragments were additionally observed (Fig 3) . For patient 32, the JS1 germline restriction fragment was more pronounced than expected on the basis of the blast percentage in the bone marrow sample and the relative intensity of the IgH germline restriction fragment (Fig 3) , which shows that part of the leukemic cell population carries a germline JS1 allele. Apparently, Southern blot patterns in the oligoclonal patients reflect ongoing rearrangements along the hierarchical TCRS recombination pathway G to V62D63/DS2DS3/"other" to deletion For 27 of 30 patients (patient 11 and the oligoclonal patients 32 and 66 were excluded), V62DS3 sequences were ~6.17.19 determined by direct sequence analysis or subcloning (patient 53; Fig 4) . There was an average of 4.6 N-nucleotides (range, 0 to 20; SD = 4.2) per sequence, the number of which was not related to age at diagnosis. N-nucleotides were absent in only 2 of 43 V62DS3 sequences (4.7%), which is less frequent than their absence observed for IgH-DJH junctional regions in B-precursor ALL (36.1%).'* Eight VS2DS3-positive patients analyzed had one or more DJH junctions without N-nucleotides.28 In these patients, a direct comparison showed that 8 of 11 DJH junctions lacked Nnucleotides, versus 1 of 12 V62DS3 junctions (P = .003, Fisher's exact test). All but four V62DS3 sequences had intact 3' RSS heptamers and apparently can be involved in further recombination (Fig 4) .
Ongoing V62D63-to-Ja rearrangements. V62DS3Ja rearrangements from all 56 bone marrow samples were amplified applying a two-step seminested PCR with primer pairs 116 and 216, respectively (Fig 1) . After the first PCR round, no PCR products could be visualized by gel electrophoresis and ethidium bromide staining. After the second PCR round, products of the expected size were observed in 23 of 30 VS2DS3-positive patients (Table l) , whereas samples from 23 of 26 VS2D63-negative patients and peripheral blood mononuclear cells analyzed in this way seemed to be VS2D63Ja-negative. For three VS2D63-negative patients, a single strong band was observed, which probably represented a primary VS2D63Ja rearrangement (data not shown). The finding of V62D63Ja PCR product mainly in the VS2DS3-positive group, suggested that most products were derived from preexisting VS2DS3 rearrangements. The latter was confirmed by hybridization with oligonucleotides complementary to the V62D63 junctional region. For 23 of 30 VS2DS3-positive patients, an oligonucleotide was tested (underscored in Fig 4) . All oligonucleotides except in patients 10, 58, 68, and 69 were positive in the hybridization assay ( Table l) . For patient 68, negativity was probably due to extension of the oligonucleotide into the RSS heptamer, which is lost after joining to a J a segment. For patient 69, ongoing rearrangements were impossible as the RSS heptamer was disrupted by an open-and-shut event.3' For patient 58, failure to detect V62D63Ja joinings may have been due to the low blast percentage (16%) in the bone marrow sample. For patient 10 there was no obvious explanation.
For 10 patients with a monoclonal V62DS3 rearrangement pattern, VS2DS3Ja PCR products were subcloned. Ten transformants were analyzed by G-tracking and sequencing of the different clones (Fig 5) . Except for clone 28-2, which probably represents a primary V62DS3Ja rearrangement, all the sequences were derived from preexisting V62D63 rearrangements as indicated by the identical V62D63 junctional region. For most patients, multiple independent V62D63-to-J~~ joinings were observed. As expected, subclones derived from rearrangements 2a and 31c, which lack an intact RSS heptamer, were not observed. For patient 31, subclones derived from a preexisting V62-(D63-inverse) (3 1-4/5) were found in addition to those derived from 31d31b.
To confirm ongoing V62DS3-to-Ja rearrangements in two patients with an oligoclonal Vd2D63 rearrangement pattern (patients 32 and 53), both V62DS3 and VS2D63Ja PCR products were subcloned and compared by G-tracking of 10 For transformants. For patient 53, a related V62D63N62D63Ja clone was identified (53-1, Fig 5) , thus confirming ongoing V62D63-to-Ja rearrangements. For patient 32, related clones were not readily detected. However, an oligonucleotide probe complementary to the V62D63 junctional region from one of the V62D63Ja clones hybridized to the V62D63 PCR product, indicating ongoing rearrangements in this patient as well (data not shown). On the basis of hybridization to V62D63 junctional region oligonucleotide probes and/or sequence analysis, ongoing V62D63-to-Ja rearrangements were confirmed in 23 of 27 (85.2%) V62D63-positive patients (Table l) . Analysis of V62D63Ja rearrangements showed a restricted Ja gene usage with HAP0532 and JaF33 in 26 of 32 and 6 of 32 V62D63Ja clones, respectively (Fig 5) . To exclude primer selection as the only cause of the biased gene usage, we designed an additional consensus Ja primer (Ja2 ;   Fig l) , homologous to most described Ja gene^.^'.^^ However, also with this primer, three of four clones contained the HAP05 Ja gene (asterisk, Fig 5) .
The D63-Ja junctional region showed normal rearrangement characteristics, with an average of 5.4 N-nucleotides (range, 0 to 15, SD = 3.7) and occasional P-nucleotides at both the 3'-D63 and 5"Ja border. The identification of P-nucleotides at the 5'-HAP05 border is putative, as the gemline sequence of this Ja gene segment is not available. Lack of N-nucleotides at the D63-Ja junction was observed for 3 of 36 clones.
V62063 rearrangements in peripheral blood lymphocytes.
Mononuclear cells from three healthy donors were analyzed. The frequency of V62D63, V62D63Ja, and non-rearranged TCRG alleles in normal B and T cells was estimated using limiting dilutions of DNA isolated from fluorescence-activated cell sorter (FACS)-sorted CD19+/CD3-and CD19-/ CD3+ peripheral blood cells as template for two-step seminested PCR. A representative experiment is shown in Fig  6. TCRG alleles in the CD19+/CD3-cell population were predominantly germline, whereas CD19-/CD3' cells had mostly rearranged TCRS loci (2% to 10% germline). V62D63 rearrangements were detected at similar frequencies in both the CD19+/CD3-cell population (0.4%, 0.08%, and 0.4% for the three donors, respectively) and the CD19-/ CD3' cell population (0.4%, 0.4%, and 0.08%, respectively). the CD19+/CD3-population are circulating pre-B cells, we tested the C D~~+ / K X + population from a fourth donor and found a similar frequency of VG2DG3-positive cells (2%). These data show that VG2-to-DG3 joining can occur during normal B-cell differentiation. V62DG3Ja rearrangements were most prominent in the CD19-/CD3+ cell population (0.016%, 0.003%. 0.003%), but were also consistently present in the undiluted CD19'/CD3-cell samples. It was noticed that amplification of VG2DG3Ja rearrangements from the CD 19'/CD3-cell population was impaired by the coamplification of a probably germline-derived l-kb PCR product that was never amplified from the T-cell population (Fig 6) .
To exclude the possibility that V62D63-rearranged cells in
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Clonal TCRG changes between diagnosis and relapse(s).
Stability of TCR6 rearrangements in the course of childhood B-precursor ALL was assessed by fingerprinting analysis of V62D63 rearrangement status at diagnosis and subsequent relapse@) ( Table 2) . For eight patients, bone marrow samples and/or bone marrow smears were available from the time of diagnosis and relapse. For only one patient (patient 22). the V62D63 rearrangement status was identical at both time points, whereas in the other seven patients, VG2D63 rearrangement status changed from diagnosis to relapse.
In three patients (patients 3, 23, and 69), a negative sample became V62D63-positive. Four patients (patients 14, 16.21, and 52) lost a V62D63 rearrangement that was present at diagnosis, which in one patient (patient 16) was replaced by a different VS2D63 joining. In the other three patients, Southern blot analysis at relapse showed that loss of V62D63 was accompanied by deletion of the 56 region ( Table 2 ). Involvement of the V62D63-to-Ja joining mechanism was investigated by VG2Ja-PCR/oligonucleotide hybridization. In only one patient (patient 21), a related V62D63Ja rearranged subclone had become the dominant clone at relapse ( Table 2) . In all four patients, the original V62D63 clone was not detectable in the relapse sample after hybridization of V62D63 PCR product to the junctional region oligonucleotide probes.
For the six patients that were assessable from first relapse to second relapse, no clonal TCRG changes were observed over the time period.
DISCUSSION
In agreement with previous studies, we found that TCRG oligoclonality at the Southern blot level is relatively rare.2'*22 This appears to be in contrast with the frequent changes in TCRG rearrangement status between diagnosis and reTherefore, we analyzed TCRG rearrangements in a a a c c c c c c c t c t a c c c a c c~~~~~T G G G G G A T could be demonstrated in the large majority of V62DS3-The use of V62D63 junctional region oligonucleotide positive patients. As V62D63Ja-rearranged subclones were probes for hybridization to V62D63Ja PCR product from also present in two patients that were oligoclonal for V62D63 the same patient allowed the screening of ALL bone marrow rearrangements (patients 32 and 53), TCRS rearrangement samples for the presence of subclones with this type of secdiversification in the leukemic cell population apparently ondary rearrangement at the PCR level. In this way, the occurs along the entire G to V62D63 to V62D63Ja pathway.
For -' 1 GAGG CTGGGGGATACG-7
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AGAGATGACAAGATCATCTTT(HAPO5) 2/7
" " " " " " " " " " " " " " " " " " " " " " " " " " " " _ GA GGGATACG-7 " " " " Hybridization and sequencing data together confirmed V62D63-to-Ja joinings in 85% of the V62D63-positive patients. Therefore, despite mostly monoclonal TCRS rearrangement patterns on Southern blot analysis,22 small subclones are present in most patients. It should be noted that G to V62D63 to V62D63Ja is not the only recombination pathway and that, apart from V62D63-to-Ja joinings, other secondary rearrangements for which we did not test are also likely to occur. The frequent occurrence of V62D63-to-Ja rearrangements could be a feature of the V62D63-positive subgroup of B-precursor ALL only. This is unlikely, however, as the majority of V62D63-negative B-precursor ALL patients have deleted TCRS l~c i '~* '~.~* (ie, a recombination step occurred further down the hierarchy of TCRG recombination), which indicates that TCR6 loci were susceptible for recombination. Our data suggest that TCR6 recombination and subclone formation at the FCR level may occur in almost all B-precursor ALL cases.
The J a locus contains about 75 different J a genes, the majority of which have not been mapped. 33 We observed a strong preferential use of the HAP05'* and JaFX3 J a gene segments in the V62D63Ja clones with two J a consensus primers that were designed to amplify most reported germline J a gene segments.32" This bias was similar to that observed for subclones of the cell line Reh obtained by limiting dilutions," which suggests a recombination preference for these J a genes. As J a F is located at the 5' end of the J a I O C U S ,~~ the observed use may reflect the preferential involvement of a restricted set of 5'-located J a genes in VG2D63-to-Ja recombination, as was also shown for initial Va-to-Ja joinings during T-cell However, primer selection cannot be ruled out. Moreover, strongly in favor of this possibility is the finding of other J a gene segments in five B-precursor ALL patients with a V62D63Ja rearrangement in the dominant c10ne.I~ For cell line Reh, exceptionally long palindromic sequences centered in the D63-Ja N-region and believed to be the result of an immature recombination machinery were reported." As similar palindromes were only observed in 4 of 36 V62D63Ja clones (underscored in Fig 5) , the above findings seem to reflect a property of cell line Reh, rather than a general feature of the V62D63-to-Ja joining process in B-precursor ALL.
The finding of V62D63 rearrangements in 5% of CD3-T-cell ALL cases'' has led to the proposal that the TCRG recombination pathway G to V62D63 to V62D63Ja is an alternative mechanism for deletion of the TCRG locus that is active in differentiating T cell^.'^.'^ Our data show that V62D63 rearrangements are also present in peripheral blood B cells. In agreement herewith is the finding that in mice transgenic for the human TCRG locus, V-to-D joining is not under the control of the enhancer 6 element (Ea) and occurs in both B and T cells.'7 V62D63Ja products could also be consistently amplified from undiluted B-cell samples despite competition for amplification by a l-kb nonspecific product. Although this suggests that the secondary step V62D63 to J a can also occur in normal B cells, the frequency is too low to exclude positivity due to contaminating CD3+ cells. The above findings indicate that at the early lymphoid progenitor stage, at least the first step along the G to V62D63 to V62DS3Ja pathway occurs in both B and T cells. Possibly, the accessibility of the TCRS locus is such that merely the active recombination machinery is required to allow a significant degree of recombination.
In B-precursor ALL, approximately 80% of the TCRS alleles are rearranged or deleted,Is whereas TCRS loci are germline in mature B-cell malignancies." A possible explanation for this difference is in line with the multistep theory of leukemogenesis in B-precursor ALL.38*39 Sequence analysis of IgH rearrangements in B-precursor ALL showed a correlation between lack of N-nucleotides at the DJHjUnCtiOn and age of disease onset, which suggested that, for some patients, the initial transformational event took place in the first trimester of fetal development.28340 Moreover, a time period of approximately 3 years between first transformational event and the acquisition of an additional mutation that leads to overt leukemia was deduced.40 It may be hypothesized that the high percentage of crosslineage TCRS rearrangements observed in B-precursor ALL is due to prolonged exposure to an active recombination machinery. Relative to the leukemic cells, normal B cells go quickly through the differentiational stage with recombination activity, which may result in a lower recombination frequency of presumably equally susceptible TCRS loci. Accordingly, our finding of N-nucleotides at V62DS3 junctions in patients that lacked N-nucleotides at their IgH-DJH junction indicates that, in these patients, VS2-to-D63 joining occurred later than Dto-JH joining.
From the above data, a hypothetical model for crosslineage TCRS rearrangements in B-precursor ALL can be deduced (Fig 7) . Apparently, subclone formation along the G to V62D63 to V62D63Ja pathway occurs in the majority of patients. Therefore, depending on the TCRS rearrangement status at the time of leukemic transformation, multiple small VS2D63, D62DS3, and/or VS2DS3Ja subclones that are different from the major clone present at diagnosis may cause relapse. Given the instability of the TCRS locus, subclones with rearrangements that involve upstream V62 gene segments are also likely to be present.
We found changes in TCRS VS2DS3 rearrangement status between diagnosis and first relapse in seven of eight patients analyzed. Previous comparisons by Southern blot analysis" and PCRZ3 reported changes in 44% and 25% of patients, respectively. The high frequency in our group is probably due to the small number of patients tested and the fact that, initially, VS2D63-negative leukemias were also included. In light of the above model, all changes (loss of VS2DS3, emergence of new V62D63, or combination of both) can be explained by the outgrowth of a small subclone that became therapy-resistant. Alternatively, these changes could also be the result of the outgrowth of a new malignant clone (second leukemia) at relapse. However, this possibility can be elimi- 
